ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018
Antibody Responses to
Open access · greenAbstract readMulticenter Study
In one paragraph
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 25 citations in OpenAlex.
- Microbiomics: Novel Biomarkers of Colorectal Cancer Diagnosis and Prognosis.Diagnostics (Basel, Switzerland) · 2026Review
- The evolving story ofFrontiers in microbiology · 2026Review
- Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery.ImmunoTargets and therapy · 2024Review
- Association of theOpen forum infectious diseases · 2023Article
- Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer.Digestive diseases and sciences · 2023Article
- Review
- Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer.Frontiers in cellular and infection microbiology · 2023Review
- Review
- Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.Journal of experimental & clinical cancer research : CR · 2022Review
- Review
- Bacterial and Parasitic Pathogens as Risk Factors for Cancers in the Gastrointestinal Tract: A Review of Current Epidemiological Knowledge.Frontiers in microbiology · 2021Review
- The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development.Frontiers in oncology · 2021Review
- Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort Consortium.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020Article
- Flurbiprofen suppresses the inflammation, proliferation, invasion and migration of colorectal cancer cells via COX2.Oncology letters · 2020Article
- Association of Combined Sero-Positivity toMicroorganisms · 2020Article
- Oral microbiota and oral cancer: Review.Oncology reviews · 2020Article
- Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.Nature reviews. Gastroenterology & hepatology · 2019Review
- Potential Role of Biofilm Formation in the Development of Digestive Tract Cancer With Special Reference toFrontiers in microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 13 institutions in 2 countries.
Julia ButtDivision of Molecular Diagnostics of Oncogenic Infections, German Cancer Research Center (DKFZ), Heidelberg, Germany. j.butt@dkfz-heidelberg.de.ORCID 0000-0001-7738-8611
William J BlotDivision of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Lauren R TerasAmerican Cancer Society, Atlanta, Georgia.
Kala VisvanathanDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
Loïc Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Christopher A HaimanUniversity of Southern California and USC Norris Comprehensive Cancer Center, Los Angeles, California.
Yu ChenDepartment of Population Health, New York University School of Medicine, New York, New York.
Ying BaoBrigham and Women's Hospital, Boston, Massachusetts.
Howard D SessoBrigham and Women's Hospital, Boston, Massachusetts.
Sylvia Wassertheil-SmollerDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-5447-4653
Gloria Y HoDepartment of Occupational Medicine, Epidemiology and Prevention, Feinstein Institute for Medical Research, Hofstra North Shore-LIJ School of Medicine, Great Neck, New York.
Lesley F TinkerWHI Clinical Coordinating Center at Fred Hutchinson Cancer Research Center, Seattle, Washington.
Richard M PeekDivision of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
John D PotterFred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0001-5439-1500
Timothy L CoverDepartment of Medicine and Department of Pathology, Microbiology Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
Laura H HendrixDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
Li-Ching HuangDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Tim WaterboerDivision of Molecular Diagnostics of Oncogenic Infections, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael PawlitaDivision of Molecular Diagnostics of Oncogenic Infections, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-4720-8306
Meira EppleinCancer Control and Population Sciences Program, Duke Cancer Institute, and Department of Population Health Sciences, Duke University, Durham, North Carolina.
Duke University · USVanderbilt University Medical Center · USBrigham and Women's Hospital · USFred Hutch Cancer Center · USGerman Cancer Research Center · DEAlbert Einstein College of Medicine · USAmerican Cancer Society · USBloomberg (United States) · USCancer Center of Hawaii · USFeinstein Institute for Medical Research · USNew York University · USUSC Norris Comprehensive Cancer Center · USVA Tennessee Valley Healthcare System · US
Funding
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8MUnderstanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4MTranslational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9MRole of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2009 to 2026
$27.5MLong Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3MSouthern Community Cohort StudyU01CA202979 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLOT, WILLIAM J., SHRUBSOLE, MARTHA J. · 2016 to 2025
$22.0MCancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0MPhysicians' Health Study II: Prevention Trial of VitaminsR01CA097193 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI GAZIANO, J. MICHAEL · 2002 to 2011
$15.7MCancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5MUnderstanding Ethnic Differences in Cancer: The Multiethnic Cohort StudyUM1CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HENDERSON, BRIAN E, LE MARCHAND, LOIC · 2012 to 2014
$11.3MH.Pylori Relationship to Digestive Diseases and CancerR01CA077955 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2003 to 2026
$9.7MStructure-function analysis of H. pylori VacAR01AI039657 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TIMOTHY L COVER · 1996 to 2026
$8.3MBLRD VA I01 BX000627NCI NIH HHS P01 CA087969NCI NIH HHS P01 CA116087NCI NIH HHS R01 CA040360NCI NIH HHS R01 CA077955NCI NIH HHS R01 CA097193NCI NIH HHS R01 CA190428NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA167552NCI NIH HHS U01 CA202979NCI NIH HHS UM1 CA164973NCI NIH HHS UM1 CA167552NCI NIH HHS UM1 CA186107NHLBI NIH HHS HHSN268201600001CNHLBI NIH HHS HHSN268201600002CNHLBI NIH HHS HHSN268201600003CNHLBI NIH HHS HHSN268201600004CNHLBI NIH HHS HHSN268201600018CNHLBI NIH HHS R01 HL034595NIAID NIH HHS R01 AI039657NIAID NIH HHS R01 AI118932NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK058587
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdolescentAdultAgedAged, 80 and overAntibodies, BacterialAntibody FormationBacterial ProteinsCase-Control StudiesColorectal NeoplasmsFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisProspective StudiesAntibodies, BacterialBacterial Proteins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.